Attached files

file filename
XML - IDEA: XBRL DOCUMENT - CytoCore IncR22.htm
EXCEL - IDEA: XBRL DOCUMENT - CytoCore IncFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - CytoCore IncR8.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR6.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR9.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR2.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR31.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR35.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR28.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR32.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR37.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR30.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR29.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR25.htm
EX-32.1 - EXHIBIT 32.1 - CytoCore Incv326519_ex32-1.htm
EX-31.1 - EXHIBIT 31.1 - CytoCore Incv326519_ex31-1.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR5.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR1.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR4.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR3.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR7.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR24.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR19.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR20.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR27.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR21.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR36.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR12.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR13.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR14.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR16.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR17.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR10.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR34.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR18.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR38.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR23.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR15.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR26.htm
10-Q - FORM 10-Q - CytoCore Incv326519_10q.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR11.htm
v2.4.0.6
Stockholders' Equity (Deficit) - Additional Information (Detail) (USD $)
In Thousands, except Share data, unless otherwise specified
9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2012
Restricted Stock [Member]
Mar. 31, 2012
Restricted Stock [Member]
Sep. 30, 2012
Restricted Stock [Member]
Selling, General and Administrative Expense [Member]
Sep. 30, 2012
Restricted Stock [Member]
Executive Director 1 [Member]
Sep. 30, 2012
Restricted Stock [Member]
Executive Director 2 [Member]
Mar. 31, 2012
Restricted Stock [Member]
Consultant [Member]
Sep. 30, 2012
Restricted Stock [Member]
Consultant [Member]
Mar. 31, 2012
Restricted Stock [Member]
Consultant [Member]
Selling, General and Administrative Expense [Member]
Mar. 31, 2012
Restricted Stock [Member]
Consultant [Member]
Research and Development Expense [Member]
Sep. 30, 2012
Restricted Stock [Member]
Consultant [Member]
Research and Development Expense [Member]
Sep. 30, 2012
Restricted Stock [Member]
Director and Vice President [Member]
Sep. 30, 2012
Restricted Stock [Member]
Director and Vice President [Member]
Selling, General and Administrative Expense [Member]
Sep. 30, 2012
Warrants and Stock Options [Member]
Sep. 30, 2011
Warrants and Stock Options [Member]
Sep. 30, 2012
Preferred Stock [Member]
Sep. 30, 2011
Preferred Stock [Member]
Stockholders Equity Note [Line Items]                                
Anti-dilutive securities not included in the computation of diluted loss per share                         922,667 1,205,762 599,075 571,754
Restricted common stocks issued for services, shares       1,200,056 1,713,019 1,066,667 849,838                  
Restricted common stocks issued for services, value     $ 53,500         $ 10,000 $ 12,000 $ 15,000            
Restricted common stocks issued for services, per share     $ 0.02         $ 0.02 $ 0.02              
Number of directors compensated 2                              
Number of consultants   2                            
Restricted common stocks issued for employee compensation, shares                     1,626,481          
Restricted common stocks issued for employee compensation, value                       $ 30,000        
Restricted common stocks issued for employee compensation, per share                       $ 0.02